[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (3): 231-237.doi: 10.3736/jcim20100306

• Original Clinical Research • Previous Articles     Next Articles

Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease: A multicenter, randomized, double-blind and placebo-controlled trial

 Ming-hui Yanga, Min Lia, Yong-qi Doia, Yi Liua, Xiao-dong Luob, Jian-zong Chenc, Heng-jun Shic   

  1. a Institute of Traditional Chinese Medicine, General Hospital of People’s Liberation Army, Beijing 100853, China;
    b Department of Internal Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510310, Guangdong Province, China
    c Department of Traditional Chinese Medicine, Xijing Hospital, Forth Military Medical University, Xi’an 710032,Shaanxi Pro vine, China
  • Received:2009-10-16 Accepted:2010-01-24 Online:2010-03-20 Published:2010-03-15
  • Contact: Min Li E-mail:kittenlee1115@126.com

RichHTML

3

PDF (PC)

468

Like

Background

The main clinical symptoms of Parkinson’s disease (PD) are resting tremor, muscle rigidity, bradykinesia, and so on. There is no effective treatment for PD yet, and dyskinesia symptoms affect the life qualities of PD patients. The therapy used for reinforcing kidney and activating blood circulation in treatment of PD can achieve good clinical effects.
Objective

To evaluate the efficacy and safety of Bushen Huoxue Granule (BSHXG), a compound traditional Chinese herbal medicine for reinforcing kidney and activating blood circulation in treatment of PD.
Design, setting, participants and interventions

A multi-center, randomized, double-blind, placebo-controlled clinical study was undertaken. A total of 120 PD patients from Outpatient Department of General Hospital of People’s Liberation Army, Guangdong Provincial Hospital of Traditional Chinese Medicine, and Xijing Hospital and Tangdu Hospital in Xi’an, were randomly divided into BSHXG group and placebo group. There were 55 cases in BSHXG group, for 5 cases lost to follow-up, and 51 cases in placebo group, for 1 case was excluded and 8 cases lost to follow-up. The patients in two groups were all treated for three months.
Main outcome measures

The movement scale, exercise testing, and muscle tension were observed before and after treatment to make a comprehensive evaluation for clinical efficacy. One month follow-up was also made.
Results

At three different times (one, two and three months) after treatment, the score of Unified Parkinson’s Disease Rating Scale (UPDRS) Ⅲ, rise time of 10-meter back and forth exercise and resting muscle tension in BSHXG group were improved as compared with before treatment (P<0.05, P<0.01), and there was an interaction between treatment time and intervention (P<0.05, P<0.01). There were no differences in evaluation results of chronograph movement (times of left and right hand movement in one minute), and walking time and turn around time of 10-meter back and forth exercise between BSHXG group and placebo group, and no interaction existed between treatment time and intervention. BSHXG showed a better efficacy than the placebo (P<0.01) in improving motor function, shortening rise time of 10-meter back and forth test and relieving muscle tension. No adverse effects were found in this trial.
Conclusion

BSHXG plus Western medicine is effective and safe in improving motor dysfunction of PD patients.

Key words: Parkinson’s disease, Reinforcing kidney, Activating blood circulation, Chinese herbal drugs, Randomized controlled trial, Double blind method, Placebo, Multicenter study

Figure 1

Flow diagram of this randomized trial"

Table 1

UPDRSⅢ scores before and after treatment in two groups (x±s)"

Group n UPDRSⅢ score
Placebo
Before treatment 51 35.1±2.0
One-month treatment 51 34.7±2.0
Two-month treatment 51 34.4±2.0
Three-month treatment 51 33.9±2.0
BSHXG group
Before treatment 55 41.3±1.9
One-month treatment 55 40.1±1.9**
Two-month treatment 55 38.7±1.9**
Three-month treatment 55 36.9±1.9**

Table 2

Evaluation of chronograph movement before and after treatment in two groups (x±s, times)"

Group n Left hand Right hand
Placebo
Before treatment 51 84.1±5.1 93.5±5.5
One-month treatment 51 89.8±5.4 96.0±5.6
Two-month treatment 51 90.8±5.5 97.8±5.7
Three-month treatment 51 91.6±5.4 98.1±5.7
BSHXG group
Before treatment 55 84.1±5.1 86.2±5.3
One-month treatment 55 87.0±5.2* 88.8±5.3*
Two-month treatment 55 86.9±5.2* 89.0±5.5*
Three-month treatment 55 88.4±5.2* 91.0±5.5*

Table 3

Evaluation of 10-meter back and forth movement before and after treatment in two groups (x±s, s)"

Group n Rise time Walking time Turn around time
Placebo
Before treatment 51 2.3±0.2 26.6±2.1 3.9±0.7
One-month treatment 51 2.3±0.2 26.0±2.0 3.8±0.7
Two-month treatment 51 2.3±0.2 26.6±1.9 4.0±0.7
Three-month treatment 51 2.3±0.2 27.1±1.9 4.0±0.7
BSHXG group
Before treatment 55 2.9±0.2 31.8±2.0 3.4±0.7
One-month treatment 55 2.8±0.2* 31.0±1.9 3.4±0.6
Two-month treatment 55 2.7±0.2* 30.0±1.8 3.2±0.7
Three-month treatment 55 2.6±0.2* 29.1±1.8 3.1±0.7

Table 4

Biceps brachii muscle tension at resting state and maximal voluntary contraction before and after treatment in two groups (x±s, kg/mm)"

Group n Resting state Maximal voluntary contraction
Left Right Left Right
Placebo
Before treatment 26 12.3±0.3 13.6±0.4 10.5±0.3 11.2±0.3
One-month treatment 26 12.3±0.3 13.6±0.4 10.6±0.3 11.2±0.3
Two-month treatment 26 12.3±0.3 13.6±0.4 10.8±0.3 11.1±0.3
Three-month treatment 26 12.3±0.3 13.4±0.3 10.9±0.3 11.1±0.4
BSHXG group
Before treatment 29 12.0±0.3 12.9±0.4 10.40±0.3 10.9±0.3
One-month treatment 29 12.2±0.3** 13.0±0.3** 10.46±0.3 11.0±0.3
Two-month treatment 29 12.4±0.3** 13.1±0.3** 10.5±0.3 13.1±0.3
Three-month treatment 29 13.5±0.3** 13.8±0.3** 10.5±0.3 13.8±0.3

Table 5

Quadriceps femoris muscle tension at resting state and maximal voluntary contraction before and after treatment in two groups (x±s, kg/mm)"

Group n Resting state Maximal voluntary contraction
Left Right Left Right
Placebo
Before treatment 26 11.7±0.4 11.7±0.4 8.9±0.3 8.5±0.2
One-month treatment 26 11.6±0.4 11.7±0.3 8.9±0.3 8.5±0.2
Two-month treatment 26 11.6±0.4 11.7±0.3 8.9±0.3 8.5±0.2
Three-month treatment 26 11.7±0.3 11.8±0.3 8.9±0.3 8.5±0.2
BSHXG group
Before treatment 29 11.7±0.4 12.5±0.3 8.5±0.3 9.2±0.2
One-month treatment 29 11.9±0.3** 12.7±0.3** 8.6±0.3 9.2±0.2
Two-month treatment 29 12.1±0.4** 12.8±0.3** 8.8±0.3 9.2±0.2
Three-month treatment 29 13.0±0.3** 13.2±0.3** 8.5±0.3 9.2±0.2
[1] Chen SD, Le WD, Chen XW. Parkinson’s disease[M]. Beijing: People’s Medical Publishing House, 2006: 59-73
陈生弟, 乐卫东, 陈先文 . 帕金森病[M]. 北京: 人民卫生出版社, 2006: 59-73
[2] Gibb UR, Lees AJ . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease[J]. J Neurol Neurosurg Psychiatry, 1988,51(6):745-752
doi: 10.1136/jnnp.51.6.745
[3] Yang MH, Dou YQ, Liu Y, Zhao GY, Luo Y . Contrast clinical observation in the treatment of Parkinson’s disease with Yichan decoction[J]. Zhongguo Zhong Xi Yi Jie He Ji Jiu Za Zhi, 2002,9(5):256-257
杨明会, 窦永起, 刘毅, 赵冠英, 罗毅 . 抑颤汤治疗帕金森病临床对照观察[J]. 中国中西医结合急救杂志, 2002,9(5):256-257
[4] Dou YQ, Yang MH, Liu Y, Wei ZM . Curative effect of integrated traditional Chinese medicine and Western medicine for treatment of patients with Parkinson’s disease: a control study[J]. Zhongguo Lin Chuang Kang Fu, 2006,10(19):6-8
窦永起, 杨明会, 刘毅, 魏正茂 . 中西医结合治疗PD疗效的对照观察[J]. 中国临床康复, 2006,10(19):6-8
[5] Leonard CT, Deshner WP, Romo JW, Suoja ES, Fehrer SC, Mikhailenok EL . Myotonometer intra- and interrater reliabilities[J]. Arch Phys Med Rehabil, 2003,84(6):928-932
doi: 10.1016/S0003-9993(03)00006-6
[6] Zheng XY. Guidelines for clinical research on Chinese new herbal medicines(trial implementation)[M]. Beijing: Medical Science and Technology Publishing House of China, 1993: 91-94
郑筱萸 . 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 1993: 91-94
[7] Bian ZX, Li YP, Moher D, Dangenais S, Liu L, Wu TX, Miu JX, Song L . Improving the quality of randomized controlled trials in Chinese herbal medicine, Part Ⅰ: clinical trial design and methodology[J]. J Chin Integr Med, 2006,4(2):120-129
卞兆祥, 李幼平, Moher D, Dangenais S, 刘良, 吴泰相, 缪江霞, 宋丽 .提高中草药随机对照试验的质量Ⅰ: 临床试验设计和方法学[J]. 中西医结合学报, 2006,4(2):120-129
[8] Gu XZ . Clinical observation of the effects of Dingchan Yin combined with Western medicine in treatment of 30 cases of Parkinson’s disease[J]. Nanjing Zhong Yi Yao Da Xue Xue Bao Zi Ran Ke Xue Ban, 2002,18(5):275-277
顾锡镇 . 西药加定颤饮治疗帕金森病30例临床观察[J]. 南京中医药大学学报: 自然科学版, 2002,18(5):275-277
[9] Zhang YH . Significance of motor function test on early stage patients with Parkinson’s disease[J]. Nao Yu Shen Jing Ji Bing Za Zhi, 2005,13(2):155-156
张燕辉 . 运动功能检测对帕金森病早期诊断的意义[J]. 脑与神经疾病杂志, 2005,13(2):155-156
[1] Na Wu , Lu Song , Xin-xin Yang, Jiang-lei Wei , Zhen-guo Liu. Effects of Chinese herbal medicine Tianqi Pingchan Granule on G protein-coupled receptor kinase 6 involved in the prevention of levodopa-induced dyskinesia in rats with Parkinson disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1018-1024.
[2] Jing-lin Shi, Wan-hong Miao. Effects of acupuncture on lactoferrin content in tears and tear secretion in patients suffering from dry eyes: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(9): 1003-1008.
[3] Ming T. Tan , Jian-ping Liu , Lixing Lao. Adequate application of quantitative and qualitative statistic analytic methods in acupuncture clinical trials. Journal of Chinese Integrative Medicine, 2012, 10(8): 847-852.
[4] Yong Zhang, Xiao-wen Sun, Jian-hua Xu, Hai Lu, Zhong-ze Fan, Jue Sun, Xiao-xiao Zhang. Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells. Journal of Chinese Integrative Medicine, 2012, 10(8): 901-910.
[5] Xin-min Li, Hui Chen, Yan-yan Ren, Yan-li Lu. Effects of Chinese herbal medicine Xifeng Capsule on multidrug resistance-associated protein 1 expression in hippocampus and cortex of rats with lithium-pilocarpine-induced epilepsy. Journal of Chinese Integrative Medicine, 2012, 10(8): 911-917.
[6] Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737.
[7] Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.
[8] Lu Yu, Shui-miao Lin, Ru-qian Zhou, Wei-jun Tang, Pin-xian Huang, Ying Dong, Jian Wang, Zhi-hua Yu, Jiu-lin Chen, Li Wei, San-li Xing, Hui-juan Cao, Hong-bin Zhao. Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(7): 766-776.
[9] Feng Xin-ying, Zhu Min, Zhang Qi-qi, Chen Yi-ping, Li Wen-wei. Selective protection of nigral dopaminergic neurons by echinacoside in a rat model of Parkinson disease induced by rotenone. Journal of Chinese Integrative Medicine, 2012, 10(7): 777-783.
[10] Hui Luo, Jian-ping Liu, Qing Li. Methodological issues and suggestions for improvement in randomized controlled trials of Chinese herbal medicine for recurrent miscarriage. Journal of Chinese Integrative Medicine, 2012, 10(6): 604-614.
[11] Peng Fu , Xue-qiang Huang, Ai-hong Yuan, Guang Yu, Xiao-bin Mei, Ruo-lan Cu. Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 641-646.
[12] Ying-fei Bi , Jing-yuan Mao , Xian-liang Wang , Ya-zhu Hou , Yi-zhu Lu , Shan Bin Soh , Bo-li Zhang. Clinical epidemiology survey of the traditional Chinese medicine etiology and syndrome differentiation of coronary artery disease: Study protocol of a multicenter trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 619-627.
[13] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640.
[14] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[15] Ying-chun Miao , Jin-zhou Tian , Jing Shi , Min Mao. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: A randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 390-397.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]